Clinical trial
Evaluating the Safety and Effectiveness of the Omnipod Horizon™ CGM-informed Bolus Calculator in Patients With Type 1 Diabetes
NCT04320069 is registered in ClinicalTrials.gov with Insulet Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Safety and Effectiveness of the Omnipod Horizon™ CGM-informed Bolus Calculator in Patients With Type 1 Diabetes
- Lead sponsor
- Insulet Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 9, 2020
- Completion date
- September 29, 2020
- Enrollment
- 25 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes